Document is current
Any future updates will be listed below
-
Authors
Lee, Jin Sun
Yost, Susan E.
Blanchard, Suzette
Schmolze, Daniel
Yin, Hongwei Holly
Pillai, Raju
Robinson, Kim
Tang, Aileen
Martinez, Norma
Portnow, Jana
Wen, Wei
Yim, John H.
Brauer, Heather Ann
Ren, Yuqi
Luu, Thehang
Mortimer, Joanne
Yuan, Yuan https://orcid.org/0000-0001-7440-8939
-
Funding
Funding for this research was provided by:
Stop Cancer (NA)
National Institutes of Health (K12CA001727)
- License Information
-
More Information
Article History
Received: 8 July 2019
Accepted: 13 September 2019
First Online: 8 November 2019
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in the study. All tumor specimens were identified through a City of Hope IRB-approved retrospective protocol from patients consented to City of Hope Biorepository Protocol.
: Not applicable
: Dr. Yuan has contracted research sponsored by Merck, Eisai, Novartis, Puma, Genentech, and Pfizer; is a consultant for Puma; and is on the Speakers Bureau for Eisai. The other authors declare that they have no competing interests.
